← Eichor
Condition: Adenoid Cystic Carcinoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Adenoid Cystic Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Tyrosine Kinase Inhibitors in Metastastic Adenoid Cystic Carcinoma
Phase 2 · 1 location(s) · Qingdao Central Hospital · NCT04974866Randomized Carbon Ions vs Standard Radiotherapy for Radioresistant Tumors
NA · 21 location(s) · Hospices Civils de Lyon · NCT02838602Adenoid Cystic Carcinoma and Carbon Ion Only Irradiation
Phase 2 · 1 location(s) · Heidelberg University · NCT04214366A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers
Phase 2 · 2 location(s) · Glenn J. Hanna · NCT06805617Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorecta
Phase 1 · 10 location(s) · Rgenta Therapeutics Inc · NCT06462183Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma
Phase 1/Phase 2 · 9 location(s) · Remix Therapeutics · NCT06118086Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers
EARLY_Phase 1 · 2 location(s) · Brigham and Women's Hospital · NCT05553782Epirubicin Interventional Chemotherapy for Sinonasal Adenoid Cystic Carcinoma (SNACC): A Prospective Study
Phase 2 · 1 location(s) · Eye & ENT Hospital of Fudan University · NCT07320508Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
Phase N/A · 4 location(s) · Vanderbilt University Medical Center · NCT00898638A Multi-omics Approach to Disclose Progression and Underlying Biology of Head and Neck Adenoid Cystic Carcinoma
Phase N/A · 1 location(s) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT07507578Surgery Plus Postoperative Radiotherapy for T4 Sinonasal Adenoid Cystic Carcinoma: A Prospective Observational Study
Phase N/A · 6 location(s) · Eye & ENT Hospital of Fudan University · NCT07652489Agnostic Therapy in Rare Solid Tumors
Phase 2 · 8 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06638931Simultaneous Integrated Boost in Carbon Ion Radiotherapy for Head and Neck Adenoid Cystic Carcinoma
NA · 1 location(s) · CNAO National Center of Oncological Hadrontherapy · NCT05733910CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC
Phase 1/Phase 2 · 1 location(s) · Glenn J. Hanna · NCT05774899A Study of Becotatug Vedotin (MRG003) Combined With Epirubicin as Neoadjuvant Therapy for EGFR-Positive, Unresectable Re
Phase 2 · 1 location(s) · Eye & ENT Hospital of Fudan University · NCT07522879Clinical Trial of HG146 Administered to Participants with Adenoid Cystic Carcinoma
Phase 2 · 1 location(s) · HitGen Inc. · NCT06781567VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Phase 1/Phase 2 · 15 location(s) · VM Oncology, LLC · NCT03556228Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
NA · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT01473784A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Expres
Phase 1 · 5 location(s) · Novelty Nobility, Inc. · NCT06805825A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06891560Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Ca
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT07162480A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Phase 1/Phase 2 · 26 location(s) · Day One Biopharmaceuticals, Inc. · NCT05377996Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial
NA · 5 location(s) · Dana-Farber Cancer Institute · NCT04883671
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.